Induced sputum and bronchoalveolar lavage from patients with hypersensitivity pneumonitis
Induced sputum and bronchoalveolar lavage from patients with hypersensitivity pneumonitis
复制标题
DOI:
10.1016/j.rmed.2004.03.007
复制
发表时间:
2004-10-01
影响因子:
4.3
通讯作者:
Olivieri, D
中科院分区:
文献类型:
--
作者:
D'Ippolito, R;Chetta, A;Olivieri, D
Background and Aim: Hypersensitivity pneumonitis (HP) is an immunologically induced inflammation of the lung parenchyma, though bronchial airways may be also involved. The aim of this study was to compare the cellular profiles of induced sputum (IS) in patients with newly diagnosed HP to that of healthy subjects, and to examine the relationship between inflammatory cells from IS and BAL.Methods: Nine HP patients and 9 healthy volunteers were studied. IS was obtained by inhalation of hypertonic saline solution in all subjects. Bronchoscopy was performed on a different occasion in all patients and in five controls.Results: IS was well tolerated and preferred to BAL by all subjects. Both IS and BAL from HP patients showed a significant increase in total cells (P < 0.02 and P < 0.001) and in lymphocytes (P < 0.02 and P < 0.001) and a significant decrease in macrophages (P < 0.05 and P < 0.001), when compared with normal subjects. In HP patients, total cells number in IS was higher than that in BAL (P < 0.02). Moreover, the percentage of lymphocytes was significantly tower in IS than in BAL (P < 0.001). No significant relationship was found between total cells or inflammatory cells from IS and the corresponding ones from BAL and wide limits of agreement were found between lymphocytes from IS and BAL.Conclusions: This study demonstrated that both BAL and IS from newly diagnosed HP patients contained significantly more total cells and lymphocytes, when compared to healthy subjects. Moreover, differential cell counts in HP patients showed that IS and BAL reflected different compartments of inflammation. Thus, IS could represent a complementary, but not alternative toot to bronchoscopy both in research and in the clinical monitoring of HP patients. (C)2004 Elsevier Ltd. All rights reserved.